Background: Vascular injury after femoral neck fracture can determine its prognosis. This study aimed to determine methods of evaluating femoral neck fracture and accurately predicting the prognosis.
Methods: Forty-five patients with a single femoral neck fracture all underwent digital subtraction angiography (DSA) and were divided into three types by DSA. DSA showing three to six supporting band vascular images crossing the fracture line was classified as type I. DSA showing one to two supporting band vascular images crossing the fracture line was classified as type II. When DSA did not show vascular images crossing the fracture line, it was classified as type III. The 45 patients were divided according to age into elderly, middle-aged and youth groups. All cases were given internal fixation operations by a hollow screw under a C-brachial machine. After a follow-up of 6-60 months, avascular necrosis of the femoral head (ANFH) and fracture healing of different type and different ages of patients were evaluated according to symptoms and imaging examinations.
Results: (1) For DSA types I, II and III, the rates of ANFH were 0, 7.14 and 100 %, respectively, and the rates of fracture disunion were 13.3, 7.15 and 0 %, respectively. Therefore, the rate of ANFH is negatively related to the visible supporting band vascular amount on DSA. (2) In the young group, the proportions of types I, II and III were 6.7, 26.67 and 66.7 %, respectively, 18.18, 36.36 and 45.45 % in the middle-aged group and 63.16, 31.58 and 5.27 % in the elderly group. The rates of necrosis for elderly, middle-aged and youth were 10.53, 45.45 and 66.67 %, respectively, and the rates of fracture disunion were 0, 0 and 6.67 %, respectively. So we can draw the conclusion that the amount of supporting band vascular images is inversely proportional to age and the union is directly related to age, but independent of the supporting band vascular amount of DSA showing.
Conclusion: The new classification after superselective angiography is valuable for predicting the prognosis of femoral neck fractures.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00776-013-0367-4 | DOI Listing |
Clin Biomech (Bristol)
December 2024
Department of Orthopedic Surgery, Hiroshima University Hospital Graduate School of Biomedical and Health Sciences, Hiroshima City, Hiroshima Prefecture, Japan.
Background: Total hip arthroplasty is the preferred treatment for advanced hip osteoarthritis, yet complications like hip dislocation (0.2 %-10 %) persist due to factors such as implant design, positioning, surgical technique, and patient-specific conditions. Impingement between prosthetic components or the acetabulum and proximal femur is a primary cause of instability.
View Article and Find Full Text PDFBMC Musculoskelet Disord
December 2024
Department of Joint Surgery, The Affiliated Hospital of Qingdao University, No. 59, Haier Road, Laoshan District, Qingdao, 266100, Shandong, People's Republic of China.
Background: Venous thromboembolism (VTE) is a common complication after hip arthroplasty. Here, we investigated the clinical efficacy and safety of prophylactic aspirin vs. conventional therapy in hip arthroplasty for femoral neck fracture.
View Article and Find Full Text PDFBMJ Case Rep
December 2024
Trauma and Orthopaedics, Lewisham and Greenwich NHS Trust, London, UK.
Background: Injectable depot medroxyprogesterone acetate (DMPA) is the most common contraceptive choice among young women in Uganda, where HIV burden is high and HIV pre-exposure prophylaxis (PrEP) may be offered. For young women who choose to use both agents concurrently, it is unknown whether they will experience declines in BMD beyond those elicited by either product singly.
Methods: From 2018-2022, we conducted a 2-year prospective study with women ages 16-25 years in Kampala, Uganda desiring pregnancy and HIV prevention.
JCEM Case Rep
January 2025
Department of Internal Medicine, Erasmus Medical Center, University Medical Center, 3015 CE, Rotterdam, the Netherlands.
A defect in the canonical Wnt-β-catenin pathway may lead to reduced bone strength and increased fracture risk. Sclerostin is a key inhibitor of this pathway by binding to low-density lipoprotein (LDL) receptor-related protein , thereby reducing bone formation. The effectiveness of romosozumab, a human monoclonal antibody that binds sclerostin and prevents this inhibitory effect, has been questioned in patients with inactivating genetic variants in or .
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!